HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

492.216

+1.1110.23%

Number of Gainers:27

Number of Losers:23

Number of Flat:1

PE:- -

High:494.856

Open:491.038

Low:485.429

Close:491.104

Volume:505.55M

Turnover:14.63B

Market Cap:3.11T

Float Cap:2.18T

Loading ...

Simcere Pharma's Half-Year Profit Jumps 48.7% on Adjusted Basis

Simcere Pharma Appoints Zhu Da as Joint Company Secretary

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

Simcere Pharmaceutical Posts HY Net Income Attributable of RMB 829 MLN

Simcere Pharmaceutical Files Board, Committee Member List with Disclosure Responsibilities

Simcere Pharmaceutical Launches Open-Market Share Buyback of up to RMB 1 Billion

Simcere Pharmaceutical - Share Repurchase Period from Aug 21, 2026 Until Next AGM or Earlier if Authority Revoked

THOMSON REUTERS

Simcere Pharmaceutical - to Repurchase Shares in Open Market up to Rmb1,000 Mln

THOMSON REUTERS

Simcere Pharmaceutical - DR. Zhou Will Serve as President

THOMSON REUTERS

Simcere Pharmaceutical - Ren Jinsheng Will Serve as Chief Executive Officer

THOMSON REUTERS

Simcere Pharmaceutical Group H1 Revenue RMB 4,580 Million

THOMSON REUTERS

China's 3SBio H1 Net Profit Falls on Higher Expenses

3SBio H1 Revenue RMB 4,526 Million

THOMSON REUTERS

KeyMed Biosciences Announces 2026 H1 Results and Business Updates

THOMSON REUTERS

Press Release: Keymed Biosciences Announces 2026 H1 Results and Business Updates

ZYLOXTB Posts 31% Revenue Growth in 2026 Interim Results, Overseas Sales Surge 349%

Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion

Zylox-Tonbridge FY26 H1 Profit Climbs 47.8% to RMB 179.1 Million; Revenue Rises 31.1% to RMB 632.04 Million

Zylox-Tonbridge Medical Technology H1 Net Income RMB 179.11 Million

THOMSON REUTERS

Jefferies Adjusts China Resources Beer (Holdings)' Price Target to HK$34.70 From HK$37.70, Keeps at Buy

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1583/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":492.21594,"timestamp":1787299686774,"preClose":491.10446,"halted":0,"volume":505549189,"delay":0,"changeRate":0.002263,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.111481,"latestTime":"08-21 16:00:00","open":491.03784,"high":494.85553,"low":485.42908,"amount":14629039215,"amplitude":0.019194,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"pbRate":2.251969,"peRate":52.53658,"turnoverRate":0.00463,"increases":26,"decrements":24,"flats":1,"marketCap":3106795119840,"floatMarketCap":2177895318528},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":494.85553,"amplitude":0.019194,"preClose":491.10446,"low":485.42908,"pbRate":"2.251969","latestPrice":492.21594,"volume":505549189,"delay":0,"open":491.03784,"prevYearClose":503.90085,"prevWeekClose":492.216,"prevMonthClose":470.497,"prevQuarterClose":402.118,"fiveDayClose":480.55,"twentyDayClose":460.614,"sixtyDayClose":442.708,"secType":"PLATE","market":"HK","turnoverRate":0.00463,"peRate":52.53658,"marketCap":3106795119840,"floatMarketCap":2177895318528,"timestamp":1787299686774,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":27,"down":23,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161013794","title":"Simcere Pharma's Half-Year Profit Jumps 48.7% on Adjusted Basis","url":"https://stock-news.laohu8.com/highlight/detail?id=1161013794","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161013794?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:02","pubTimestamp":1787238152,"startTime":"0","endTime":"0","summary":"Simcere Pharma (02096) has announced its interim results for 2026, reporting total revenue of RMB 4.58 billion, up 27.8% year-on-year. Revenue from innovative drugs reached RMB 3.887 billion,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147857859","title":"Simcere Pharma Appoints Zhu Da as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1147857859","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147857859?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:02","pubTimestamp":1787238146,"startTime":"0","endTime":"0","summary":"Simcere Pharma (02096) has announced a change in its company secretarial roles. Mr. Wan Yushan has stepped down as Joint Company Secretary, effective August 20, 2026, while retaining his positions as...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660336292","title":"China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2660336292","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660336292?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:02","pubTimestamp":1787238137,"startTime":"0","endTime":"0","summary":"China's Simcere Pharmaceutical H1 revenue rises on neuroscience, autoimmune drugs strengthOverviewChina pharmaceutical maker's interim revenue grew 27.8% yr/yr for six months ended June 2026Net income","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951186391.HKD","LU0072913022.USD","LU0203345920.USD","IE00B5MMRT66.SGD","LU0289739343.SGD","HK0000165453.HKD","LU0689626769.HKD","LU1152091168.USD","IE00BZ08YR35.GBP","LU0511384066.AUD","BK1521","LU0124676726.USD","LU0289961442.SGD","BK1583","BK1515","MADE","LU1226288253.USD","SG9999004220.SGD","BK4533","LU0501845795.SGD","IE0008368742.USD","IE00BZ08YT58.USD","BK4585","IE000M9KFDE8.USD","BK4588","LU1226287529.USD","LU0880133367.SGD","BK4567","IE00B543WZ88.USD","LU1226287875.USD","LU1328277881.USD","LU1993786604.SGD","CMI","LU1008478684.HKD","IE00BZ08YS42.EUR","LU1960683339.HKD","LU0154245673.USD","LU2463526074.USD","BK1191","KURE","LU1152091754.HKD","LU0140636845.USD","LU0057025933.USD","02096","01093","LU2039709279.SGD","BK4149","LU0154245756.USD","IE00B031HY20.USD","LU0067412154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233313","title":"Simcere Pharmaceutical Posts HY Net Income Attributable of RMB 829 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233313?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:55","pubTimestamp":1787237734,"startTime":"0","endTime":"0","summary":"BRIEF-Simcere Pharmaceutical Posts HY Net Income Attributable Of RMB 829 MLNAug 20 (Reuters) - Simcere Pharmaceutical Group H1 net income attributable RMB 829 million.H1 revenue RMB 4,580 millionREN JINSHENG WILL SERVE AS CHIEF EXECUTIVE OFFICERDR. ZHOU WILL SERVE AS PRESIDENT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXR1LBPG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233392","title":"Simcere Pharmaceutical Files Board, Committee Member List with Disclosure Responsibilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233392","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233392?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:55","pubTimestamp":1787237702,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical files board, committee member list with disclosure responsibilitiesSimcere set out its board and committee memberships in an Aug. 20, 2026 filing.Ren Jinsheng remains chairman, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL3jT45Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660380233","title":"Simcere Pharmaceutical Launches Open-Market Share Buyback of up to RMB 1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660380233","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660380233?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:53","pubTimestamp":1787237588,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical launches open-market share buyback of up to RMB 1 billionSimcere launched an open-market share buyback worth up to RMB 1 billion, starting Aug. 21.Program runs until the next an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL7G1PZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233806","title":"Simcere Pharmaceutical - Share Repurchase Period from Aug 21, 2026 Until Next AGM or Earlier if Authority Revoked","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233806?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:52","pubTimestamp":1787237521,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0TQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660023387","title":"Simcere Pharmaceutical - to Repurchase Shares in Open Market up to Rmb1,000 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2660023387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660023387?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:52","pubTimestamp":1787237521,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0TQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660803233","title":"Simcere Pharmaceutical - DR. Zhou Will Serve as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2660803233","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660803233?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:51","pubTimestamp":1787237499,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1BP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233821","title":"Simcere Pharmaceutical - Ren Jinsheng Will Serve as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233821","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233821?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:51","pubTimestamp":1787237499,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233817","title":"Simcere Pharmaceutical Group H1 Revenue RMB 4,580 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233817","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233817?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:50","pubTimestamp":1787237405,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXR1LBPG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660384532","title":"China's 3SBio H1 Net Profit Falls on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660384532","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660384532?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:37","pubTimestamp":1787236626,"startTime":"0","endTime":"0","summary":"China's 3SBio H1 net profit falls on higher expensesOverviewChina biopharmaceutical firm's half-year revenue rose 3.9% yr/yrNet profit attributable to shareholders fell 15.6% yr/yrGross profit increas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0M8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4149","BK1191","BK1583","BK4533","BK1515","IE00BZ08YS42.EUR","BK4567","HK0000165453.HKD","LU0069063385.USD","LU0154245756.USD","LU0472753341.HKD","01177","BK4585","LU0203347892.USD","BK1521","IE00BZ08YT58.USD","BK1161","LU0154245673.USD","LU0689626769.HKD","LU0289739343.SGD","LU0124676726.USD","LU0289961442.SGD","LU0203345920.USD","BK1593","LU0057025933.USD","BK4588","BK1589","LU2463526074.USD","LU0511384066.AUD","01530","MADE","IE00BZ08YR35.GBP","CMI","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660591238","title":"3SBio H1 Revenue RMB 4,526 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660591238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660591238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:28","pubTimestamp":1787236090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLX9N116F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1583","BK1161","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427280","title":"KeyMed Biosciences Announces 2026 H1 Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427280","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427280?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:10","pubTimestamp":1787235014,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA5MDWKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1574","02162","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660232280","title":"Press Release: Keymed Biosciences Announces 2026 H1 Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660232280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660232280?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:10","pubTimestamp":1787235000,"startTime":"0","endTime":"0","summary":"CHENGDU, China, Aug. 20, 2026 /PRNewswire/ -- On August 19, 2026, Keymed Biosciences (HKEX: 02162) announced its interim results for the six months ended June 30, 2026. Guided by a clear dual-engine d","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BD","BK4096","PN","BK1587","BK1583","02162","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114693671","title":"ZYLOXTB Posts 31% Revenue Growth in 2026 Interim Results, Overseas Sales Surge 349%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114693671","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114693671?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:51","pubTimestamp":1787233900,"startTime":"0","endTime":"0","summary":"ZYLOXTB (HKEX: 02190) unveiled its interim results for the first half of 2026 on August 20, showcasing robust financial performance. The company recorded operating revenue of RMB 632 million for the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02190","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287767","title":"Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287767","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287767?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:40","pubTimestamp":1787233202,"startTime":"0","endTime":"0","summary":"Chinese medical device maker Zylox-Tonbridge's revenue rises 31%, aided by global expansionOverviewChina medical device maker's H1 revenue rose 31.1% yr/yr, driven by device sales growthNet profit for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867","BK1515","HK0000165453.HKD","BK1100","SG9999004220.SGD","BK1521","SG9999015986.USD","IE00BZ08YT58.USD","IE00BMCWC346.EUR","BK1585","BK1587","BK1191","IE00BZ08YR35.GBP","01696","LU2488822045.USD","01177","BK1583","BK1589","02190","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","BK1230","BK1593","00656","IE00BYV24P56.USD","BK1574","IE00BGHQDM52.EUR","SG9999015978.USD","IE00BZ08YS42.EUR","SG9999015952.SGD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287145","title":"Zylox-Tonbridge FY26 H1 Profit Climbs 47.8% to RMB 179.1 Million; Revenue Rises 31.1% to RMB 632.04 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287145","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287145?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:29","pubTimestamp":1787232592,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge FY26 H1 profit climbs 47.8% to RMB 179.1 million; revenue rises 31.1% to RMB 632.04 millionZylox-Tonbridge posted IFRS profit for the period of RMB 179.11 million, up 47.8%, as revenue","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL3Qm0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1100","BK1574","02190","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287130","title":"Zylox-Tonbridge Medical Technology H1 Net Income RMB 179.11 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287130?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:29","pubTimestamp":1787232559,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLX6FQ377:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1574","BK1587","02190","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660841932","title":"Jefferies Adjusts China Resources Beer (Holdings)' Price Target to HK$34.70 From HK$37.70, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660841932","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660841932?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:29","pubTimestamp":1787228992,"startTime":"0","endTime":"0","summary":"China Resources Beer (Holdings) (HKG:0291) has an average rating of buy and mean price target of HK$32.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic r","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1521","LU1769817179.HKD","IE00B0169L03.USD","LU1328615791.USD","IE00B29SXG58.USD","BK1510","LU1023057109.AUD","LU1720050803.USD","BK1578","BK1589","LU0328353924.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","IE0031814852.USD","IE0008369823.USD","LU1769817096.USD","IE0008368742.USD","BK1570","BK1604","BK1583","IE00B031HY20.USD","IE00B543WZ88.USD","LU1794554557.SGD","LU0359201612.USD","CRHKY","00291","BK1180","LU0359202008.SGD","SG9999006514.SGD","80291"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":4,"totalSize":354,"code":"91000000","status":"200"}]}}